ILC3 in Axial Spondyloarthritis: the Gut Angle.
Ankylosing spondylitis
Group 3 innate lymphoid cells
Gut inflammation
IL-17
IL-23/IL-17 axis
Lymphoid tissue inducer cells
Spondyloarthritis
Journal
Current rheumatology reports
ISSN: 1534-6307
Titre abrégé: Curr Rheumatol Rep
Pays: United States
ID NLM: 100888970
Informations de publication
Date de publication:
13 06 2019
13 06 2019
Historique:
entrez:
15
6
2019
pubmed:
15
6
2019
medline:
2
10
2020
Statut:
epublish
Résumé
A growing body of evidence supports the relevance of the interleukin-23/interleukin-17 (IL-23/IL-17) pathway for the pathogenesis of axial spondyloarthritis (axSpA) and its treatment. Recently, innate lymphoid cells (ILC), a heterogeneous family of immune effector cells, have been identified as a relevant contributor in tissue homeostasis, partially via IL-23/IL-17 axis. This review describes the biology and the origins of the group 3 ILCs (ILC3s) in humans, focusing on their role in the pathogenesis of axSpA. Clinical trials showed the effectiveness of IL23/IL-17 axis inhibition in both spondyloarthritis (SpA) and Inflammatory Bowel Disease (IBD). Recent findings confirm the high prevalence of subclinical gut inflammation in patients with SpA. Translational data in humans have demonstrated an increase in the number of ILC3s responsive to IL-23 and producing either IL-22 or IL-17 in the gut of SpA patients. The observation of gut-derived ILC3s in circulation and at inflamed tissues in patients with SpA suggest a recirculation of ILCs from mucosal site to lymphoid tissues and possibly enthesis and joints. Multiple observations demonstrate the expansion of IL-17- and IL-22-producing ILC3 in the subclinically inflamed gut of SpA patients. These innate immune cells, also observed in normal entheses, seem to be able to re-circulate from the gut to inflamed tissues of SpA patients, thus contributing to the disease perpetuation. The development of tools that can provide access to diseased tissue from sacroiliac joint and spinal entheses will provide valuable knowledge on the role of ILC3 in axSpA pathogenesis.
Identifiants
pubmed: 31197599
doi: 10.1007/s11926-019-0834-9
pii: 10.1007/s11926-019-0834-9
doi:
Substances chimiques
Interleukin-17
0
Interleukin-23
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
37Références
Eur J Immunol. 1975 Feb;5(2):117-21
pubmed: 1086218
Rev Rhum Mal Osteoartic. 1976 Oct;43(10):541-51
pubmed: 1086503
Cell. 2006 Sep 22;126(6):1121-33
pubmed: 16990136
Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6347-52
pubmed: 17404233
J Exp Med. 2007 May 14;204(5):1119-30
pubmed: 17452521
Arthritis Rheum. 2007 Aug;56(8):2633-9
pubmed: 17665420
Nat Immunol. 2007 Oct;8(10):1086-94
pubmed: 17873879
Nat Med. 2008 Mar;14(3):282-9
pubmed: 18264109
Nat Immunol. 2009 Jan;10(1):66-74
pubmed: 19029905
Mucosal Immunol. 2008 May;1(3):198-207
pubmed: 19079179
Immunity. 2008 Dec 19;29(6):958-70
pubmed: 19084435
Methods Mol Biol. 2009;531:71-87
pubmed: 19347312
Immunity. 2009 Sep 18;31(3):513-25
pubmed: 19733489
Nat Immunol. 2009 Nov;10(11):1178-84
pubmed: 19783988
J Exp Med. 2009 Dec 21;206(13):3101-14
pubmed: 20008524
Trends Immunol. 2010 Feb;31(2):50-5
pubmed: 20015688
Nature. 2010 Jan 28;463(7280):540-4
pubmed: 20023630
Nat Rev Immunol. 2010 Jun;10(6):415-26
pubmed: 20498668
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11489-94
pubmed: 20534524
Rheumatology (Oxford). 2010 Nov;49(11):2076-83
pubmed: 20688803
Science. 2010 Oct 29;330(6004):665-9
pubmed: 20929731
Adv Immunol. 2010;108:21-44
pubmed: 21056728
Nat Immunol. 2011 Jan;12(1):21-7
pubmed: 21113163
J Exp Med. 2011 Jan 17;208(1):125-34
pubmed: 21173107
Arthritis Res Ther. 2011 Jun 20;13(3):R95
pubmed: 21689402
Nat Immunol. 2011 Sep 11;12(11):1055-62
pubmed: 21909091
Arthritis Rheum. 2012 Jan;64(1):99-109
pubmed: 21968742
Arthritis Rheum. 2012 May;64(5):1420-9
pubmed: 22144400
Arthritis Rheum. 2012 Jun;64(6):1869-78
pubmed: 22213179
Immunity. 2012 Jan 27;36(1):55-67
pubmed: 22261438
Arthritis Rheum. 2012 Jul;64(7):2211-22
pubmed: 22328069
J Exp Med. 2012 Apr 9;209(4):729-40
pubmed: 22430492
Blood. 2012 May 31;119(22):5250-60
pubmed: 22504926
Semin Immunol. 2012 Jun;24(3):165-74
pubmed: 22541512
Front Immunol. 2012 Apr 09;3:72
pubmed: 22566953
Nat Med. 2012 Jul 01;18(7):1069-76
pubmed: 22772566
Immunity. 2012 Oct 19;37(4):649-59
pubmed: 23063330
Immunity. 2012 Oct 19;37(4):634-48
pubmed: 23063333
Nature. 2013 Feb 7;494(7435):116-20
pubmed: 23334413
Nat Immunol. 2013 Mar;14(3):221-9
pubmed: 23334791
Nat Rev Immunol. 2013 Feb;13(2):145-9
pubmed: 23348417
Immunity. 2013 Apr 18;38(4):769-81
pubmed: 23453631
Immunol Cell Biol. 2013 Jul;91(6):390-2
pubmed: 23732616
Ann Rheum Dis. 2014 Jun;73(6):1186-9
pubmed: 24276368
J Exp Med. 2013 Dec 16;210(13):2939-50
pubmed: 24323357
Nature. 2014 Apr 17;508(7496):397-401
pubmed: 24509713
Immunity. 2014 Mar 20;40(3):378-88
pubmed: 24631153
Nature. 2014 Apr 3;508(7494):123-7
pubmed: 24670648
Cell. 2014 Apr 10;157(2):340-356
pubmed: 24725403
J Exp Med. 2014 Jul 28;211(8):1571-83
pubmed: 25024136
Arthritis Rheumatol. 2014 Oct;66(10):2780-92
pubmed: 25048686
J Exp Med. 2014 Aug 25;211(9):1733-40
pubmed: 25092873
J Exp Med. 2014 Aug 25;211(9):1723-31
pubmed: 25113970
PLoS One. 2014 Aug 20;9(8):e105684
pubmed: 25140823
Nat Immunol. 2014 Oct;15(10):929-937
pubmed: 25151491
Immunity. 2014 Sep 18;41(3):366-374
pubmed: 25238094
Arthritis Rheumatol. 2015 Mar;67(3):686-691
pubmed: 25417597
Arthritis Res Ther. 2014 Nov 30;16(6):486
pubmed: 25434931
Immunity. 2014 Dec 18;41(6):988-1000
pubmed: 25500367
Nature. 2015 Mar 12;519(7542):242-6
pubmed: 25533952
Immunol Lett. 2015 May;165(1):1-9
pubmed: 25794634
Ann Rheum Dis. 2015 Sep;74(9):1739-47
pubmed: 25902790
Arthritis Rheumatol. 2015 Oct;67(10):2673-8
pubmed: 26137857
Immunity. 2015 Jul 21;43(1):146-60
pubmed: 26187413
J Allergy Clin Immunol. 2016 Jan;137(1):75-86.e8
pubmed: 26194544
Ann Rheum Dis. 2015 Sep;74(9):1633-5
pubmed: 26199396
Immunity. 2015 Jul 21;43(1):29-40
pubmed: 26200011
Immunity. 2015 Aug 18;43(2):394-407
pubmed: 26287684
Gastroenterology. 1989 Feb;96(2 Pt 1):339-44
pubmed: 2637670
Immunol Cell Biol. 2016 May;94(5):421-9
pubmed: 26647966
Trends Immunol. 2016 Jan;37(1):68-79
pubmed: 26708278
J Exp Med. 2016 Apr 4;213(4):569-83
pubmed: 26976630
Ann Rheum Dis. 2016 Dec;75(12):2124-2132
pubmed: 27165176
Immunity. 2016 May 17;44(5):1140-50
pubmed: 27178467
Arthritis Rheumatol. 2017 Jan;69(1):114-121
pubmed: 27390077
Eur J Immunol. 2016 Sep;46(9):2111-20
pubmed: 27485474
Curr Allergy Asthma Rep. 2016 Oct;16(10):73
pubmed: 27645534
J Allergy Clin Immunol. 2016 Nov;138(5):1265-1276
pubmed: 27677386
Immunity. 2017 Jan 17;46(1):148-161
pubmed: 27986455
Ann Rheum Dis. 2017 Jun;76(6):1123-1132
pubmed: 28069576
J Immunol. 2017 Mar 1;198(5):1798-1803
pubmed: 28115527
Cell Rep. 2017 Feb 14;18(7):1761-1773
pubmed: 28199847
Cell. 2017 Mar 9;168(6):1086-1100.e10
pubmed: 28283063
JCI Insight. 2017 Mar 9;2(5):e90063
pubmed: 28289707
Parasite Immunol. 2018 Feb;40(2):
pubmed: 28423191
Arthritis Rheumatol. 2017 Sep;69(9):1816-1822
pubmed: 28511289
Sci Rep. 2017 Jun 21;7(1):3980
pubmed: 28638068
J Immunol. 2017 Oct 1;199(7):2333-2342
pubmed: 28842466
Cell. 2017 Sep 21;171(1):201-216.e18
pubmed: 28844693
Cold Spring Harb Perspect Biol. 2018 Dec 3;10(12):null
pubmed: 29229782
Arthritis Rheumatol. 2018 Apr;70(4):555-565
pubmed: 29287307
Blood Adv. 2017 Mar 30;1(10):577-589
pubmed: 29296700
J Immunol. 2018 Feb 15;200(4):1249-1254
pubmed: 29330320
J Leukoc Biol. 2018 Mar;103(3):409-419
pubmed: 29345366
Immunol Rev. 2018 May;283(1):54-76
pubmed: 29664571
Arthritis Rheumatol. 2018 Dec;70(12):2003-2013
pubmed: 29869839
Cell. 2018 Aug 23;174(5):1054-1066
pubmed: 30142344
Br J Rheumatol. 1988;27 Suppl 2:95-105
pubmed: 3042080
Ann Rheum Dis. 2019 Apr;78(4):494-503
pubmed: 30700427
J Exp Med. 2019 Apr 1;216(4):728-742
pubmed: 30814299
Gastroenterology. 1996 Jun;110(6):1696-703
pubmed: 8964393
Immunity. 1997 Oct;7(4):493-504
pubmed: 9354470